Highlights Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
31.71 ^CNY	-0.91%		-2.25%	+0.89%

27/06	Hubei Jumpcan Pharmaceutical Obtains Drug Registration for Antibiotic Injection; Shares Down 3%	MT
20/06	Hubei Jumpcan Pharmaceutical Gets Drug Registration Certificate for Allergy Drug; Shares Slide 3%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hubei Jumpcan Pharmaceutical Obtains Drug Registration for Antibiotic Injection; Shares Down 3%	27/06	MT
Hubei Jumpcan Pharmaceutical Gets Drug Registration Certificate for Allergy Drug; Shares Slide 3%	20/06	MT
Jumpcan Pharmaceutical Adjusts Repurchase Price Cap After Annual Share Distribution	11/06	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03/04	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03/01	CI
Jumpcan Pharma Registers Two New Drugs	02/11	MT
Hubei Jumpcan Pharma’s Q3 Profit Jumps 4.8%, Revenue Falls 6%	23/23/23	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	22/23/22	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	10/23/10	CI
Hubei Jumpcan Pharma Logs Double-Digit Earnings Growth in H1 on Strong Sales, Reduced Costs; Shares Jump 5%	14/23/14	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13/23/13	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	04/23/04	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	03/23/03	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/23/17	CI
China's Weibo ups stake in Inmyshow Digital with $315 million acquisition	01/23/01	RE
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Hubei Jumpcan Pharmaceutical’s Q3 Profit Rises 38% as Revenue Jumps 18%; Shares Up 5%	24/22/24	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/22/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

Highlights

Filters